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ABSTRACT
The substantial therapeutic potential of tempol (4-hydroxy-2,2,6,6-tetramethyl-1-piperidinyloxy) and related cyclic
nitroxides as antioxidants has stimulated innumerous studies of their reactions with reactive oxygen species. In com-
parison, reactions of nitroxides with nitric oxide-derived oxidants have been less frequently investigated. Nevertheless,
this is relevant because tempol has also been shown to protect animals from injuries associated with inflammatory
conditions, which are characterized by the increased production of nitric oxide and its derived oxidants. Here, we
review recent studies addressing the mechanisms by which cyclic nitroxides attenuate the toxicity of nitric oxide-
derived oxidants. As an example, we present data showing that tempol protects mice from acetaminophen-induced
hepatotoxicity and discuss the possible protection mechanism. In view of the summarized studies, it is proposed that
nitroxides attenuate tissue injury under inflammatory conditions mainly because of their ability to react rapidly with
nitrogen dioxide and carbonate radical. In the process the nitroxides are oxidized to the corresponding oxammonium
cation, which, in turn, can be recycled back to the nitroxides by reacting with upstream species, such as peroxynitrite
and hydrogen peroxide, or with cellular reductants. An auxiliary protection mechanism may be down-regulation of
inducible nitric oxide synthase expression. The possible therapeutic implications of these mechanisms are addressed.
Key words: cyclic nitroxides, tempol, antioxidants, nitric oxide-derived oxidants, inflammation, acetaminophen-
induced hepatotoxicity.
INTRODUCTION
In spite of the substantial evidence indicating that oxida-
tive mechanisms contribute to the pathogenesis of many
human diseases, multiple large prospective intervention
trials with classical antioxidants, such as vitamin C, vita-
min E and β-carotene, failed to have a significant impact
upon disease risk and progression (Brennan and Hazen
2003, Kris-Etherton et al. 2004). Among the many rea-
sons responsible for such inconclusive results, an early
lack of appreciation for the roles of nitric oxide-derived
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oxidants in pathologic processes and the limited actions
of classical antioxidants should be included (Brennan
and Hazen 2003, Szabo et al. 2007). Thus, it is conceiv-
able that a better understanding of the mechanisms by
which non-classical antioxidants, such as uric acid and
tempol, protect animals during conditions of oxidative
stress may contribute to the design of new antioxidant
strategies to treat human diseases (Augusto et al. 2002).
Tempol (4-hydroxy-2,2,6,6-tetramethyl-1-piperidi-
nyloxy) and other cyclic nitroxides are particularly ef-
fective at reducing oxidative injury in cell and animal
models (for recent reviews, see Soule et al. 2007, Ka-
gan et al. 2007). Also known as aminoxyls and nitro-
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xyls, these compounds are stable free radicals due to the
three electron bond between N and O and the presence
of α-substituents (usually methyl groups) that preclude
radical-radical dismutation (Fig. 1). Due to their stabil-
ity and paramagnetic nature, cyclic nitroxides have been
extensively employed as probes in biophysical studies.
In addition, nitroxides are multifunctional antioxidants
because of their ability to react with diverse biological
oxidants and reductants while being recycled through
oxammonium cation- (TPNO+) and hydroxylamine-de-
rivatives (TPNOH), respectively (Fig. 1). Eventually,
nitroxides can be consumed by recombination reactions
with certain radicals, such as thiyl radicals, and these
reactions are likely to be important in nitroxide metabol-
ism (Fig. 1) (Borisenko et al. 2004a).
The most cited antioxidant mechanism of nitrox-
ides is their superoxide dismutase activity, probably be-
cause it was the first property elucidated at the molecu-
lar level (Krishna et al. 1992). Other investigated nitrox-
ide antioxidant mechanisms include inhibition of Fen-
ton chemistry by the ability to oxidize transition metal
ions, termination of radical chain reactions by radical
recombination and acceptance of electrons from the mi-
tochondrial electron transport chain (Soule et al. 2007,
Kagan et al. 2007). In comparison, reactions of cyclic
nitroxides with nitric oxide-derived oxidants have been
less frequently investigated and discussed. This is rele-
vant, however, because tempol has also been shown to
protect animals from injuries associated with inflamma-
tory conditions (reviewed in Thiemermann 2003), which
are characterized by increased production of nitric oxide
and its derived oxidants (reviewed in Radi 2004).
Thus, it is timely to critically review recent studies
that address the mechanisms by which cyclic nitroxides
in general, and tempol in particular, attenuate the tox-
icity of nitric oxide-derived oxidants. This protection
is accompanied by decreased levels of protein tyrosine
nitration in tissues, exemplified in mice treated with an
overdose of acetaminophen, which will be examined and
discussed in consideration of recent mechanistic stud-
ies (Bonini et al. 2002, Goldstein et al. 2003a, b, 2004,
2006, Fernandes et al. 2005, Linares et al., in press, Vaz
and Augusto 2006). The possible therapeutic implica-
tions of these mechanisms will also be addressed.
PROTECTIVE EFFECTS OF TEMPOL ARE PARALLELED
BY DECREASED LEVELS OF PROTEIN TYROSINE
NITRATION
It has long been recognized that nitric oxide, in addi-
tion to its signaling properties, can act as a cytotoxic
effector when produced at high rates by either inflam-
matory stimuli-induced nitric oxide synthase (iNOS) or
overstimulation of the constitutive forms. The cytotoxic
effects of nitric oxide are largely dependent on the for-
mation of oxidants that are more reactive towards bio-
molecules than itself, such as peroxynitrite (ONOOH/
ONOO−), nitrogen dioxide (NO•2) and carbonate radical
(CO•−3 ). Peroxynitrite is produced from the diffusion-
controlled reaction of nitric oxide (NO•) with the su-
peroxide radical (O•−2 ), whereas nitrogen dioxide and
carbonate radicals are produced in yields of 35% each
from the reaction of peroxynitrite with carbon dioxide
(Fig. 2). In addition, nitrogen dioxide can be produced
from nitric oxide reaction with oxygen in hydrophobic
environments where these gases concentrate, peroxyni-
trite reaction with hemeproteins and nitrite oxidation by
hemeperoxidase enzymes (reviewed in Augusto et al.
2002, Radi 2004). On the other hand, nitrite is a bio-
logical product and precursor of nitric oxide (Gladwin
et al. 2005).
The first recognized molecular footprint of the for-
mation of nitric oxide-derived oxidants in vivo was the
occurrence of 3-nitrotyrosine residues in tissue proteins
(Beckman et al. 1994). Presently, it is known that bio-
logical nitration can occur at tyrosine and tryptophan
residues, lipids and nucleic acid bases, but tyrosine nitra-
tion continues to attract the most attention because of its
high occurrence in proteins and the sensitive detection of
3-nitrotyrosine in biological samples by immunological
techniques. As a post-translational modification, pro-
tein tyrosine nitration has been evaluated as a potential
indicator of acute and chronic disease states and a pre-
dictor of disease risk. In the case of infectious diseases,
the occurrence of protein tyrosine nitration in infected
tissues and cells has been considered evidence for the
involvement of nitric oxide-derived oxidants in phago-
cyte microbicidal mechanisms (reviewed in Radi 2004).
It is important to mention that biological protein
nitration occurs with low yields because the dominant
An Acad Bras Cienc (2008) 80 (1)
NITROXIDES AGAINST NITRIC OXIDE-DERIVED OXIDANTS 181
N
OH
OH
e-/H+
e-/H+ N
OH
e
-
e- N
OH
O
+
.
N
OH
OX
Products
O.
X
TPNOH TPNO TPNO
+.
metabolism
Fig. 1 –Main biological redox reactions of tempol (TPNO•), a cyclic nitroxide of the six-membered piperidine class.
In addition to the reversible redox reactions, tempol is consumed by recombination reactions with alkyl, alkoxyl,
tyrosyl and thiyl radicals. The latter are likely to be important in nitroxide metabolism (Borisenko et al. 2004a).
reactions of nitric oxide and derived oxidants are those
with abundant biological reagents, such as oxygen, car-
bon dioxide and biothiols (Lancaster 2006). Thus, pro-
tein thiol oxidation, glutathiolation and nitrosation are
also important post-translational protein modifications
caused by nitric oxide-derived oxidants. However, in
addition to protein nitration, only protein thiol nitrosa-
tion can directly reveal production of nitric oxide-derived
oxidants.
Protein tyrosine nitration under physiological con-
ditions occurs by a free radical mechanism that involves
recombination between nitrogen dioxide and protein ty-
rosyl radicals (Augusto et al. 2002, Radi 2004). Thus,
efficient protein tyrosine nitration requires systems that
direct or indirectly produce tyrosyl radicals in addition
to nitrogen dioxide. Examples of such systems are per-
oxynitrite/carbon dioxide and hemeperoxidases, such
as myeloperoxidase (MPO)/ and eosinophil peroxidase
(EPO)/hydrogen peroxide/nitrite. More recently, other
hemeproteins, such as COX-2 (Palazzolo-Ballance et al.
2007) and iNOS (Marechal et al. 2007), have been pro-
posed as catalysts of biological protein tyrosine nitra-
tion. All of these reactants and enzymes are consid-
ered to be important players in inflammatory processes.
Thus, it is not surprising that in protecting experimental
animals from injury associated with inflammatory condi-
tions, tempol also decreased tissue protein nitration lev-
els (reviewed in Thiemermann 2003).
In line with the general literature trend, however,
the protective effects of tempol were mainly attributed
to its superoxide dismutase activity that precludes
hydroxyl radical and peroxynitrite formation. The pos-
sibility of tempol scavenging both hydroxyl radicals and
peroxynitrite was also discussed (Thiemermann 2003).
However, nitroxides are not particularly efficient super-
oxide dismutase (SOD) mimics (Goldstein et al. 2003b)
and it was unlikely that local concentrations of adminis-
tered tempol could surpass superoxide dismutase isoen-
zymes, which are abundant in most physiological envi-
ronments. Likewise, administered tempol was unlikely
to compete with endogenous targets for hydroxyl radi-
cals, which react with most biomolecules at diffusion-
controlled rates. A reaction between tempol and per-
oxynitrite also appeared unlikely because we had pre-
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Fig. 2. 
Fig. 2 – Schematic representation of the mechanism by which tempol shifts peroxynitrite reactivity towards
proteins from nitration to nitrosation. P represents a generic protein. The reactions are not balanced and the
scheme summarizes the known reactions of tempol with peroxynitrite/carbon dioxide-derived radicals and
the main reactions of proteins with nitrogen dioxide and carbonate radicals (shown by solid arrows). The
recombination reactions that produce PtyrNO2 and PcysNO and those that consume tempol precluding its
continuous recycling are also shown by dashed arrows (Fernandes et al. 2005, Vaz and Augusto 2006).
viously shown that peroxynitrite did not react directly
with desferal and its derived nitroxide (Denicola et al.
1995). Thus, it was relevant to examine the interaction of
tempol with peroxynitrite, peroxynitrite/carbon dioxide
(Bonini et al. 2002) and MPO/hydrogen peroxide/nitrite
in vitro (Vaz and Augusto 2006), cell culture (Fernandes
et al. 2005) and mice (this work; also, Linares et al. in
press). These studies, taken togetherwith parallel studies
by Goldstein and co-workers (Goldstein et al. 2003a, b,
2004, 2006), provided important information about the
mechanisms by which tempol and related nitroxides can
attenuate the toxicity of nitric oxide-derived oxidants.
TEMPOL DIVERTS PEROXYNITRITE REACTIVITY
TOWARDS PROTEINS FROM NITRATION TO
NITROSATION
In our initial studies in vitro, we demonstrated that
tempol does not react directly with peroxynitrite but,
instead, reacts with peroxynitrite-derived radicals to de-
activate them while being oxidized to the oxammonium
cation, which is recycled back to tempol by oxidizing
the remaining peroxynitrite to nitric oxide and oxygen.
Tempol recycling is not continuous because part of it
is consumed by reactions with protein-derived radicals
(Fig. 2). Thus, tempol diverts peroxynitrite reactivity
from nitrating to nitrosating mechanisms in vitro (Boni-
ni et al. 2002) and in cells (Fernandes et al. 2005). Our
conclusion was extended by parallel studies of Golds-
tein and co-workers (Goldstein et al. 2003a, b, 2004,
2006), who determined the second order rate constants
of tempol and tempo and their corresponding oxammo-
nium cation- and hydroxylamine-derivatives with a se-
ries of oxidants, including nitric oxide-derived oxidants
(Table I). Tempo, the tempol analogue that lacks the
4-OH group (Fig. 1), was prioritized because its ox-
ammonium cation is more stable and easier to study ki-
netically. All of the data collected in Table I will be
discussed later.
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TABLE I
Reactions of tempol (TPNO•), oxammonium cation (TPNO+) and hydroxylamine (TPNOH)
with biological intermediates and the corresponding second order rate constants.
Reaction
Rate constant
Comments Ref.
(M−1 s−1)
TPNO• + NO•
2
kf= 8.7× 108
pH 3.0-10.0 Goldstein et al. 2003a
 TPNO+ + NO−
2
kr= 2.7× 105
TPNO•+ CO•−
3
+ H+
4.0× 108 pH 10.3 Goldstein et al. 2004→ TPNO+ + HCO−
3
TPNO•+•OH→ products 4.5× 109 pH 7.4 Samuni et al. 2002
TPNO• + MPO-I ∼ 106 pH 7.4 Vaz and Augusto 2006→ TPNO+ + MPO-II
TPNO• + HRP-I ∼ 103 pH 7.4 Vaz and Augusto 2006→ TPNO+ + HRP
TPNO• + GS• ∼ 108
Value estimated
Borisenko et al. 2004b→ TPNO-SG
from kinetic
simulations for a
tempo derivative;
pH 7.0
TPNO• + P-tyr• ∼ 106
Value obtained
Vaz and Augusto 2006→ TPNO-tyrP
from kinetic
simulations;
pH 7.4
TPNO• + H+ + L-Fe(II)
K = 3.7× 103(M−1) Phosphate buffer, Bar-On et al. 1999
 TPNOH + L-Fe(III) pH 7.1
TPNO++ ONOO−
6.0× 106
Value obtained
Goldstein et al. 2004→ TPNO• + NO• + O2
for tempo-
oxammonium
cation; pH 5.0
TPNO+ + NO•+ H2O
9.8× 103
Value obtained
Goldstein et al. 2004→ TPNO• + NO−
2
+ 2H+
for tempo-
oxammonium
cation; pH 6.8
TPNO+ + HO−
2
kf= 1.1× 108
Values obtained
Aronovitch et al. 2007
 TPNO• + HO•
2
kr= 1.2× 108
for tempo-
oxammonium
cation
TPNO+ + O•−
2 3.4× 109
Value obtained
Goldstein et al. 2003b→ TPNO• + O2
for tempo-
oxammonium
cation; pH 7.6
TPNOH + NO•
2 k ≤ 105 pH 3.0-10.0 Goldstein et al. 2003a→ TPNO• + NO−
2
TPNOH + CO•−
3 k = 1.7× 108 pH 10.3 Goldstein et al. 2004→ TPNO• + HCO−
3
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To examine whether tempol mechanisms in vivo re-
late with those operating in vitro (Fig. 2), we selected
mice treated with an overdose of acetaminophen as our
first animal model. Although a safe and effective anal-
gesic at therapeutic levels, acetaminophen overdoses
cause hepatotoxicity, which, in severe cases, leads to
liver failure in experimental animals and humans. De-
spite substantial efforts, the mechanism of acetamino-
phen overdose hepatotoxicity is still not completely un-
derstood. Atfirst, emphasiswas placedon itsmetabolism
to N-acetyl-p-benzoquinone mediated by cytochrome
P450. More recently, nitric oxide-derived oxidants pro-
duced by an inflammatory response emerged as a poten-
tial secondary mediator of hepatocyte cell death (Deni-
cola and Radi 2005). Indeed, accumulating evidence
indicates that leukocyte infiltration, inflammatory cy-
tokines, iNOS expression and increased nitric oxide pro-
duction contribute to acetaminophen-promoted liver in-
jury (Knight et al. 2002, Ishida et al. 2002). Our re-
sults confirmed that administration of an overdose of ac-
etaminophen (500 mg/kg; i.p) to mice caused liver dam-
age because the plasma of the treated animals presented
activity of a characteristic liver enzyme, alanine amino-
transferase (ALT) (Fig. 3). Acetaminophen-induced
liver damage was markedly inhibited by tempol, which
also reduced protein 3-nitrotyrosine while increasing ni-
trite and nitrosothiol levels in the centrolobular liver tis-
sue (Fig. 3). Such behavior in an animal model is anal-
ogous to that observed for bovine serum albumin and
cells treated with a bolus of peroxynitrite in the presence
of tempol (Fig. 2) (Fernandes et al. 2005). Thus, our re-
sults support a role for peroxynitrite in acetaminophen-
induced hepatotoxicity (Fig. 3).
INHIBITION OF IN VIVO LEISHMANICIDAL
MECHANISM BY TEMPOL
The second animal model we investigated was a chronic
infection model, the relatively resistant C57/Bl6 mice
infected with Leishmania amazonensis (Linares et al. in
press). Previously, based on several lines of evidence, we
proposed that C57Bl/6mice are able to control cutaneous
L. amazonensis infection mainly because their footpad
macrophages are activated at an early infection stage to
produce peroxynitrite-derived radicals that are crucial to
parasite elimination (Linares et al. 2001). Thus, tempol
could worsen infection because of its ability to neutralize
peroxynitrite-derived radicals.
Since L. amazonensis is a chronic model, tempol
was administered in the drinking water at 2 mM through-
out the experiments (1-15 weeks) and it was shown to
reach infected footpads by EPR analysis of tissue ho-
mogenates. This analysis revealed the presence of tem-
pol in the homogenates as two of the forms shown in
Fig. 1, the nitroxide (∼30%) and the hydroxylamine-
derivative (∼70%). At the time of maximum infection
(6 weeks), tempol increased footpad lesion size (120%)
and parasite burden (150%). In lesion extracts, tempol
decreased overall nitric oxide products and expression of
inducible nitric oxide synthase to about 80% of control
animals. Nitric oxide-derived products that are formed
by radical mechanisms, such as 3-nitrotyrosine and ni-
trosothiol, decreased to about 40% of control mice.
The effect of tempol in decreasing iNOS expression is
probably due to its capacity to reduce NF-κB activa-
tion, as shown before in an acute model of inflammation
in mice, carrageenan-induced pleuritis (Cuzzocrea et al.
2004). Taken together, our results indicated that tempol
worsened L. amazonensis infection by a dual mech-
anism involving down-regulation of iNOS expression
and scavenging of nitric oxide-derived oxidants (Linares
et al. in press).
It is instructive to compare the results obtained
with the above mice models. In the acute model, inhi-
bition of iNOS expression is not apparent because ni-
trite levels are increased rather than decreased by tem-
pol (Fig. 3). Although in both models tempol decreased
protein tyrosine nitration levels in the affected tissues,
nitrosothiol levels increased in the acute model but de-
creased in the chronic model. Considering our in vitro
studies (Fig. 2), we could infer that peroxynitrite is likely
to be involved in acetaminophen-induced liver damage
but not in parasite killing. At this point, however, this
conclusion appears premature. On the one hand, the data
are limited and levels of nitric oxide-derived products,
such as nitrate, nitrite and nitrosothiols, in animal tissues
are influenced by many factors that remain to be fully
characterized (Bryan et al. 2004). On the other hand, it
is presently accepted that formation of both nitrosothiols
and 3-nitrotyrosine occurs by radicalmechanisms (Bryan
et al. 2004, Lancaster 2006), which, in principle, can be
An Acad Bras Cienc (2008) 80 (1)
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Fig. 3 – Effects of tempol in protecting acetaminophen-induced hepatotoxicity. (A) Plasma alanine aminotransferase (ALT) and 3-nitrotyrosine
protein residue levels in the liver centrolobular tissue. (B) Nitrite and nitrosothiol levels in the liver centrolobular tissue. Male C3Heb/FeJ mice
(18 to 20 g) were fasted overnight and treated with acetaminophen (AAP) pre-dissolved in warm saline (500 mg/kg, i.p). Tempol was administered
1 and 4 h afterwards (24mg/kg, i.p). Animals were sacrificed 6 h after AAP injection. The liver was perfused with cold saline containing 10
mM N-ethylmaleimide and centrolobular tissue was removed and homogenized as previously described (Fernandes et al. 2005). Plasma alanine
aminotransferase (Tsuhako et al. 2006) and levels of 3-nitrotyrosine, nitrite and nitrosothiol in centrolobular tissues (Fernandes et al. 2005)
were quantified as described in the cited references. The inset shows a typical analysis of 3-nitrotyrosine by its staining compared with protein
staining; BSA and BSA-TyrNO2 corresponds to bovine serum albumin untreated and treated with peroxynitrite/carbon dioxide used as controls.
The experiments are representative of at least three control, APP- and APP-treated plus tempol animals.
inhibited by tempol (Figs. 1 and 2). A shift of perox-
ynitrite reactivity from nitration to nitrosation by tempol
may become detectable only when local tempol concen-
trations are high enough to produce a sufficient amount
of oxammonium cations to oxidize peroxynitrite to nitric
oxide, as occurs upon a bolus addition of peroxynitrite to
proteins and cells (Fig. 2) and, apparently, in the acute
acetaminophen-induced model of inflammation (Fig. 3).
In fact, tempol plus its hydroxylamine-derivative level
measured in the footpads of mice infected with L. ama-
zonensis was found to be around 1 µM, whereas, in
the blood of acetaminophen-treated mice, it was about
10 times higher (data not shown) because the animals
received two doses of tempol (24 mg/kg, i.p.) 1 and
4 h after acetaminophen administration (Fig. 3). Cer-
tainly, further studies are required to establish whether
changes in the profile of nitric oxide-derived products by
tempol may become a strategy to discriminate between
different nitric oxide-derived oxidants in vivo. A step
in this direction was to study the effects of tempol on
hemeperoxidase-mediated protein nitration.
INHIBITION OF HEMEPEROXIDASE-MEDIATED PROTEIN
TYROSINE NITRATION BY TEMPOL
Recently, we examined the effects of tempol on protein
nitration mediated by myeloperoxidase (MPO), a mam-
malian enzyme that plays a central role in innate im-
mune defense and various inflammatory processes. For
comparative purposes, some experiments were also per-
formed with HRP, an abundant plant peroxidase that
is frequently used as a model of mammalian peroxi-
dases. As the nitration target, we employed RNase, a
model protein that contains 6 tyrosines, no tryptophan
and all of 8 cysteines involved in intramolecular disulfide
bonds (Vaz and Augusto 2006). Our results showed that
tempol efficiently inhibits peroxidase-mediated RNase
nitration. For instance, 10 µM tempol was able to in-
hibit by 90% the yield of 290 µM 3-nitrotyrosine pro-
duced from 370 µM RNase. Also, we showed that tem-
pol reacts with MPO-I and HRP-I with second order rate
constants that are orders of magnitude higher (106 and
103 M−1 s−1, respectively) than that reported for ferryl-
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myoglobin (101 M−1 s−1) (Krishna et al. 1996). Nev-
ertheless, the determined rate constants were not high
enough for tempol (10 µM) competing with nitrite
(1 mM) for MPO-I and HRP-I. This was confirmed by
substrate (nitrite and hydrogen peroxide) consumption
and product (3-nitrotyrosine and oxygen) formation
quantification and modeling by kinetic simulations. It
was concluded that the inhibitory effect of tempol was
mainly due to its reaction with nitrogen dioxide to pro-
duce the oxammonium cation, which, in turn, recycled
back to tempol by reacting with hydrogen peroxide and
superoxide radicals to produce oxygen and regenerate
nitrite (Fig. 4). Another relevant tempol reaction was
with RNase tyrosyl radicals, which consumed the ni-
troxide and precluded its continuous recycling (Vaz and
Augusto 2006). Overall, this mechanism presents simi-
larities to the one proposed for tempol diversion of
peroxynitrite/carbon dioxide reactivity in vitro and cells
(Fig. 2).
These studies were important because a significant
fraction of nitric oxide-derived oxidants produced in
vivo are likely to depend on reactions catalyzed by
mammalian hemeperoxidases, such as MPO and eosino-
phil peroxidase (EPO) (Radi 2004, Szabo et al. 2007).
In addition, the peroxidase activity of prostaglandin en-
doperoxide H synthase (Palazzolo-Ballance et al. 2007)
and the oxygenase domain of inducible nitric oxide syn-
thase (Marechal et al. 2007) have been recently pro-
posed as possible sources of nitrogen dioxide in mam-
mals. Since MPO is a very reactive peroxidase, our de-
monstration that tempol efficiently inhibits myeloperox-
idase-mediated protein nitration should also hold for
other mammalian peroxidases.
CONCLUSIONS AND THERAPEUTIC IMPLICATIONS
Most of the discussed reactions of tempol and its redox
active forms, the oxammonium cation and the hydroxy-
lamine (Fig. 1), with biological intermediates and their
corresponding second order rate constants are collected
in Table I. As we observed in the case of mice infected
with L. amazonensis (Linares et al. in press), the pre-
dominant form of tempol appears to be the hydroxy-
lamine because of the reducing physiological environ-
ment (Linares et al. in press). Since tempol is usually
more reactive than the hydroxylamine towards bi-
ological intermediates (Table I), it is likely to be more
important to scavenge them. The hydroxylamine deriva-
tives certainly react with oxidants in vivo but theymay be
better suited to function as reservoirs of nitroxides. Thus,
we propose that nitroxides attenuate the toxic effects
of nitric oxide-derived oxidants mainly because of their
ability to react rapidly with nitrogen dioxide and carbon-
ate radicals (k> 108M−1 s−1) that would otherwise at-
tack a variety of biological targets, causing oxidative and
nitro-oxidative damage (Fig. 4). In addition, cyclic ni-
troxidesmay down-regulate iNOS expression, as demon-
strated in the case of tempol administration to mice in-
fected with L. amazonensis (Linares et al. in press). In
reacting with nitric oxide-derived radicals, nitroxides
are oxidized to the corresponding oxammonium cation,
which, in turn, may be recycled back to the nitroxide
by reacting with upstream species, such as peroxyni-
trite and hydrogen peroxide, to regenerate nitric oxide,
superoxide radicals and oxygen (Fig. 4, Table I). In
vivo, it is likely that oxammonium cation can be re-
cycled by physiological reductants but these reactions
have yet to be explored (Goldstein et al. 2003a). The
most abundant physiological reductants, such as GSH
and NAD(P)H, once oxidized may be repaired by en-
zymatic systems but, in the case of a pronounced re-
dox imbalance, reductant-derived radicals may partici-
pate in oxidative reactions and contribute to tissue dam-
age (Fig. 4). Such reactions may be responsible for the
toxicity associated with high doses of nitroxides (Soule
et al. 2007, Kagan et al. 2007).
Because tempol is quite effective at reducing in-
flammatory injury in genuine physiological conditions,
specifically in animal models (Thiemermann 2003), it
is conceivable that targeting nitroxides to cells and sites
of increased nitric oxide-derived oxidant production
may become a potential therapeutic strategy. A proof
of the concept is found in the promising results obtained
by targeting nitroxides to mitochondria and mitochon-
drial membranes to reduce oxygen-derived radical lev-
els (Dhanasekaran et al. 2005, Kagan et al. 2007). On
the other hand, the long-known tempol radioprotective
effects are being explored for use in both clinical radi-
ation oncology and radiological emergency situations,
such as nuclear power plant disasters or terrorist attacks
(Soule et al. 2007). Relevantly, a pilot study showed that
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Fig. 4 – Schematic representation of sources of nitric oxide-derived oxidants and tempol effects/reactions proposed to attenuate tissue injury
in inflammatory conditions. The scheme presents an extremely simplified overview where the nitric oxide is produced by activated leukocytes
hypothetically expressing iNOS, and NOX (phagocyte oxidase) and liberatingMPO. Other possibilities, such as expression of COX-2, are omitted.
The reactions are not balanced, intermediates are omitted for clarity and the possibility of the oxammonium cation (TPNO+) being recycled by
cellular reductants is omitted for lack of data (see text). The hydroxylamine-derivative (grey) is proposed to function as a reservoir of tempol but
its reactions are not shown (see Fig. 1). Reactions downstream of nitric oxide and superoxide radicals leading to oxidants capable of promoting
oxidative tissue damage are marked with full lines, whereas protective reactions are marked with interrupted lines.
topical tempol application resulted in significant preven-
tion of radiation-induced alopecia in patients receiving
cranial radiation.
In conclusion, this overview supports the develop-
ment of therapeutic strategies based on nitroxides as an-
tioxidants. Because of the dual role of nitric oxide-
derived oxidants in inflammatory tissue injury and mi-
croorganism control, however, a potential increased risk
of infection should be contemplated.
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RESUMO
O considerável potencial terapêutico de tempol (4-hidroxi-2,2,
6,6-tetrametil-1piperiniloxila) e nitróxidos cíclicos relaciona-
dos como antioxidantes tem estimulado inúmeros estudos de
suas reações com espécies reativas derivadas de oxigênio. Em
comparação, as reações de nitróxidos com oxidantes deriva-
dos do óxido nítrico têm sido investigadas menos frequente-
mente. Todavia, essas reações são relevantes porque o tempol
é também capaz de proteger animais de injúrias associadas a
condições inflamatórias, as quais são caracterizadas por uma
aumentada produção de óxido nítrico e derivados oxidantes.
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Aqui, discutimos estudos recentes abordando os mecanismos
pelos quais nitróxidos cíclicos atenuam a toxicidade de oxi-
dantes derivados do óxido nítrico. Como um exemplo, apresen-
tamos dados que demonstram que o tempol protege camundon-
gos do dano hepatotóxico promovido por altas doses de ace-
taminofeno e discutimos o possível mecanismo de proteção.
Com base nos estudos sumarizados, é proposto que nitróxidos
atenuam a injúria tecidual em condições inflamatórias devido
principalmente a sua capacidade de reagir rapidamente com
ambos, dióxido de nitrogênio e radical carbonato. Em conse-
qüência, os nitróxidos são oxidados ao cátion oxamônio corres-
pondente, o qual, por sua vez, pode ser reciclado ao nitróxido
através de reações com espécies precursoras, como peroxini-
trito e peróxido de hidrogênio, ou com redutores celulares. Um
possível mecanismo auxiliar de proteção é a regulação negativa
da expressão da sintase do óxido nítrico induzível. As possíveis
implicações terapêuticas desses mecanismos são abordadas.
Palavras-chave: nitróxidos cíclicos, tempol, antioxidantes,
oxidantes derivados do óxido nítrico, inflamação, hepatotoxi-
cidade induzida por acetaminofeno.
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